Total Payments
$22,032
2024 Payments
$2,542
Companies
55
Transactions
1,497
Medicare Patients
4,644
Medicare Billing
$355,099
Payment Breakdown by Category
Food & Beverage$21,734 (98.6%)
Education$297.73 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,734 | 1,486 | 98.6% |
| Education | $297.73 | 11 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,782 | 206 | $0 (2024) |
| ABBVIE INC. | $2,312 | 138 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,209 | 122 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,791 | 127 | $0 (2024) |
| Lilly USA, LLC | $1,265 | 104 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,005 | 70 | $0 (2022) |
| Allergan, Inc. | $865.61 | 98 | $0 (2020) |
| PFIZER INC. | $809.69 | 65 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $742.81 | 55 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $713.18 | 52 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,542 | 130 | ABBVIE INC. ($549.39) |
| 2023 | $2,484 | 145 | ABBVIE INC. ($459.64) |
| 2022 | $2,194 | 131 | ABBVIE INC. ($475.06) |
| 2021 | $2,824 | 179 | AbbVie Inc. ($570.57) |
| 2020 | $2,735 | 177 | Novo Nordisk Inc ($432.14) |
| 2019 | $3,013 | 225 | AstraZeneca Pharmaceuticals LP ($437.96) |
| 2018 | $3,543 | 269 | Novo Nordisk Inc ($509.76) |
| 2017 | $2,697 | 241 | AstraZeneca Pharmaceuticals LP ($428.72) |
All Payment Transactions
1,497 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.13 | General |
| Category: Opioid Analgesic | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: PAIN | ||||||
| 10/21/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.35 | General |
| Category: Opioid Analgesic | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,284 | 4,405 | $275,067 | $96,699 |
| 2022 | 19 | 1,351 | 4,098 | $285,601 | $102,490 |
| 2021 | 13 | 1,001 | 2,452 | $190,733 | $85,650 |
| 2020 | 14 | 1,008 | 2,367 | $199,072 | $70,260 |
Total Patients
4,644
Total Services
13,322
Medicare Billing
$355,099
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 71 | 703 | $3,515 | $557.02 | 15.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 12 | 13 | $923.00 | $536.73 | 58.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 119 | 147 | $2,205 | $326.21 | 14.8% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2022 | 13 | 20 | $560.00 | $277.00 | 49.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 13 | $429.00 | $213.48 | 49.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 51 | 279 | $2,790 | $97.15 | 3.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 44 | 1,010 | $252.50 | $84.38 | 33.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 29 | 54 | $825.00 | $70.96 | 8.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 15 | 76 | $76.00 | $33.89 | 44.6% |
| J0690 | Injection, cefazolin sodium, 500 mg | Office | 2022 | 11 | 26 | $130.00 | $20.05 | 15.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 214 | 541 | $113,069 | $48,083 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 133 | 133 | $21,812 | $17,323 | 79.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 90 | 144 | $20,448 | $8,566 | 41.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 39 | $10,998 | $4,915 | 44.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 67 | 188 | $9,212 | $1,949 | 21.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 12 | 12 | $3,900 | $1,836 | 47.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 117 | 129 | $4,257 | $1,202 | 28.2% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 17 | 20 | $1,900 | $578.82 | 30.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 122 | 186 | $1,116 | $558.00 | 50.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 111 | 124 | $1,860 | $279.00 | 15.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 31 | 294 | $1,470 | $258.26 | 17.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 25 | 520 | $130.00 | $54.33 | 41.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2021 | 27 | 122 | $561.30 | $46.42 | 8.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 242 | 603 | $126,027 | $41,363 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 113 | 113 | $18,532 | $12,659 | 68.3% |
About Dr. Martin Molina, M.D
Dr. Martin Molina, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700830338.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Molina, M.D has received a total of $22,032 in payments from pharmaceutical and medical device companies, with $2,542 received in 2024. These payments were reported across 1,497 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($21,734).
As a Medicare-enrolled provider, Molina has provided services to 4,644 Medicare beneficiaries, totaling 13,322 services with total Medicare billing of $355,099. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 05/19/2006
- Last Updated 03/02/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700830338
Products in Payments
- FARXIGA (Drug) $1,742
- Ozempic (Drug) $1,195
- TRELEGY ELLIPTA (Drug) $1,117
- VRAYLAR (Drug) $1,094
- UBRELVY (Drug) $865.97
- NURTEC ODT (Drug) $815.49
- XARELTO (Drug) $683.57
- Vascepa (Drug) $640.43
- TRULICITY (Drug) $553.31
- TRINTELLIX (Drug) $488.91
- Victoza (Drug) $488.65
- Rybelsus (Drug) $419.42
- XIFAXAN (Drug) $404.06
- ANORO (Drug) $386.33
- APLENZIN (Drug) $354.53
- JARDIANCE (Drug) $351.25
- Belbuca (Drug) $342.01
- Aimovig (Biological) $323.69
- TOUJEO (Drug) $319.90
- INVOKANA (Drug) $315.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Family Medicine $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
Family Medicine $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Family Medicine $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Family Medicine $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Family Medicine $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768
Family Medicine $32,768